Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2001 | |
| Cash Flows From Operating Activities | |
| Net Income | 4,900 |
| Depreciation Amortization | 42,600 |
| Income taxes - deferred | -2,400 |
| Accounts receivable | -3,000 |
| Accounts payable and accrued liabilities | 11,100 |
| Other Working Capital | 16,600 |
| Other Operating Activity | -8,200 |
| Operating Cash Flow | $61,600 |
| Cash Flows From Investing Activities | |
| PPE Investments | 700 |
| Other Investing Activity | 8,700 |
| Investing Cash Flow | $9,400 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -13,200 |
| Other Financing Activity | 34,700 |
| Financing Cash Flow | $21,500 |
| End Cash Position | 68,000 |
| Net Cash Flow | $68,000 |
| Free Cash Flow | |
| Operating Cash Flow | 61,600 |
| Capital Expenditure | -20,800 |
| Free Cash Flow | 40,800 |